Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Analyze which crypto assets deliver real project utility, looking at use cases, partnerships, and on-chain activity to gauge authenticity.
28,337 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Investors are weighing the fate of the retiring cruise ship dream as the cruise industry rebounds. The reality check:...
A veteran Blythewood broker unveils REMAX Reliable Realty, bringing a high-producing south carolina team into the REM...
Goldman Sachs lowers its 12-month oil-price target to align with current market levels as traders weigh the prospects...
A seasoned advisor makes a bold move, unloading nearly $5 million in value stocks and doubling down on a market-timin...
Intel stock crashed week as three pressures converged, turning a rally into a sharp pullback. This article breaks dow...
Once-skeptical of SaaS valuations, this longtime saas bear now highlights real value in beaten-down software. He shar...
A disturbing case shows how a grandmother lost $100k cash to a cash pickup scam. This article breaks down the scam me...
A billionaire hedge fund manager shows the power of high-conviction bets in AI. This article breaks down Ackman'...
A viral comparison claims pokémon cards beat 2.5x the S&P 500 over two decades, but analysts warn that rising fees, i...
Howard Hanna Holdings has reached a master settlement to resolve a wave of homebuyer commission lawsuits, signaling a...
Geopolitics can shake travel stocks fast. This article breaks down how Carnival, the world’s largest cruise operator,...